Jun 15, 2020
Medicure Announces Top Line Data from FABOLUS-FASTER Trial With AGGRASTAT® will be Presented at the PCR e-Course, Late Breaking Trial Sessions, June 27, 2020
Mar 10, 2020
Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China
Dec 24, 2019
Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events
Dec 17, 2019
Medicure Announces the Completion of Shortened AGGRASTAT® Versus Integrilin® in Percutaneous Coronary Intervention (SAVI-PCI) Study
Dec 12, 2019
Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Dec 11, 2019
Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value
Dec 05, 2019
Medicure Announces Settlement of Holdback Dispute from Apicore Sale
Dec 05, 2019
Medicure Files Patent Infringement Action
Nov 07, 2019
Correvio to Report Third Quarter 2019 Financial Results
Sep 27, 2019
Correvio to Present at the 2019 Cantor Global Healthcare Conference
Aug 21, 2019
Medicure Announces Settlement of Patent Infringement Action
Aug 08, 2019
Correvio to Report Second Quarter 2019 Financial Results
Jun 18, 2019
Correvio Announces Voting Results
May 01, 2019
Correvio to Report First Quarter 2019 Financial Results on May 8, 2019
Apr 02, 2019
Correvio to present at the H.C. Wainwright Global Life Sciences Conference
Mar 07, 2019
Correvio to Present at Upcoming Investor Conferences
Mar 06, 2019
Correvio To Report Fourth Quarter And Full Year 2018 Financial Results On March 13, 2019
Feb 21, 2019
Correvio to Participate in the 8th Annual SVB Leerink Global Healthcare Conference
Jan 28, 2019
Medicure Announces Agreement to Market ReDS(TM) Device for Congestive Heart Failure Patients in the United States
Nov 20, 2018
Correvio to Present at the 30th Annual Piper Jaffray Healthcare Conference